- Home
- Lobbying firms
- Lmh Strategic Solutions
Lmh Strategic Solutions
Lobbying firm · Jul 2025 – Sep 2026
Lmh Strategic Solutions earned $4.1M lobbying for 25 clients (Jul 2025 – Sep 2026). Biggest clients: Midsized Biotech Alliance Of America, Alkermes, Inc., Bicycle Therapeutics.
- Lobbying income
- $4.1M
- Clients
- 25
Clients
- Midsized Biotech Alliance Of America$460K
- Alkermes, Inc.$300K
- Bicycle Therapeutics$300K
- Alnylam Pharmaceuticals, Inc.$240K
- Avadel Pharmaceuticals, Plc$240K
- Incyte Corporation$240K
- Regenxbio Inc.$240K
- Ptc Therapeutics, Inc.$200K
- Glaxosmithkline LLC$190K
- Ionis Pharmaceuticals, Inc.$180K
- Stealth Biotherapeutics Inc.$180K
- Harmony Biosciences$160K
- Neuropace, Inc.$160K
- Savara Inc.$150K
- Ardelyx, Inc.$120K
- The Erisa Industry Committee$120K
- Pharmaceutical Research And Manufacturers Of America$120K
- Medical Device Manufacturers Association$80K
- Travere Therapeutics$80K
- Acadia Pharmaceuticals Inc.$60K
- Biomarin Pharmaceutical, Inc.$60K
- Exelixis, Inc.$60K
- Neurocrine Biosciences, Inc.$60K
- Rezolute$40K
- Natera Inc$20K
More
From Lobbying Disclosure Act reports.
Cite or embed this page
Capitol Receipts, “Lmh Strategic Solutions: Lobbying Firm Clients & Income,” https://www.capitolreceipts.com/lobbying-firm/flmhstrategicsolutions/lmh-strategic-solutions (accessed 2026-10-17).